De Angel, Valeria http://orcid.org/0000-0002-5109-3636
Lewis, Serena
White, Katie
Oetzmann, Carolin
Leightley, Daniel http://orcid.org/0000-0001-9512-752X
Oprea, Emanuela
Lavelle, Grace http://orcid.org/0000-0003-3768-1797
Matcham, Faith
Pace, Alice
Mohr, David C. http://orcid.org/0000-0002-5443-7596
Dobson, Richard
Hotopf, Matthew
Funding for this research was provided by:
NIHR Maudsley Biomedical Research Centre
Article History
Received: 28 July 2021
Accepted: 28 November 2021
First Online: 11 January 2022
Competing interests
: M.H. is principal investigator of the RADAR-CNS programme, a precompetitive public–private partnership funded by the Innovative Medicines Initiative and European Federation of Pharmaceutical Industries and Associations. The programme receives support from Janssen, Biogen, MSD, UCB and Lundbeck. D.C.M. has accepted honoraria and consulting fees from Apple, Inc., Otsuka Pharmaceuticals, Pear Therapeutics, and the One Mind Foundation, royalties from Oxford Press, and has an ownership interest in Adaptive Health, Inc. All other authors declare that they have no competing interests.